153 related articles for article (PubMed ID: 19651494)
1. Fitness cost of macrolide resistance in Campylobacter jejuni.
Han F; Pu S; Wang F; Meng J; Ge B
Int J Antimicrob Agents; 2009 Nov; 34(5):462-6. PubMed ID: 19651494
[TBL] [Abstract][Full Text] [Related]
2. Fitness of macrolide resistant Campylobacter coli and Campylobacter jejuni.
Zeitouni S; Collin O; Andraud M; Ermel G; Kempf I
Microb Drug Resist; 2012 Apr; 18(2):101-8. PubMed ID: 22324770
[TBL] [Abstract][Full Text] [Related]
3. Macrolide resistance in Campylobacter jejuni and Campylobacter coli.
Gibreel A; Taylor DE
J Antimicrob Chemother; 2006 Aug; 58(2):243-55. PubMed ID: 16735431
[TBL] [Abstract][Full Text] [Related]
4. Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni.
Almofti YA; Dai M; Sun Y; Haihong H; Yuan Z
Microb Pathog; 2011 Jun; 50(6):336-42. PubMed ID: 21377522
[TBL] [Abstract][Full Text] [Related]
5. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni.
Hao H; Dai M; Wang Y; Peng D; Liu Z; Yuan Z
Microb Drug Resist; 2009 Dec; 15(4):239-44. PubMed ID: 19857128
[TBL] [Abstract][Full Text] [Related]
6. The physiologic and phenotypic alterations due to macrolide exposure in Campylobacter jejuni.
Almofti YA; Dai M; Sun Y; Hao H; Liu Z; Cheng G; Yuan Z
Int J Food Microbiol; 2011 Nov; 151(1):52-61. PubMed ID: 21875757
[TBL] [Abstract][Full Text] [Related]
7. A possible mechanism of macrolide resistance among multiple resistant Campylobacter jejuni and Campylobacter coli isolated from Thai children during 1991-2000.
Serichantalergs O; Jensen LB; Pitarangsi C; Mason CJ; Dalsgaard A
Southeast Asian J Trop Med Public Health; 2007 May; 38(3):501-6. PubMed ID: 17877226
[TBL] [Abstract][Full Text] [Related]
8. Survival at refrigeration and freezing temperatures of Campylobacter coli and Campylobacter jejuni on chicken skin applied as axenic and mixed inoculums.
El-Shibiny A; Connerton P; Connerton I
Int J Food Microbiol; 2009 May; 131(2-3):197-202. PubMed ID: 19324444
[TBL] [Abstract][Full Text] [Related]
9. Comparison of adhesion, invasion, motility, and toxin production of Campylobacter strains and their resistant mutants.
Zeitouni S; Guyard-Nicodème M; Kempf I
Microb Drug Resist; 2013 Apr; 19(2):130-7. PubMed ID: 23095083
[TBL] [Abstract][Full Text] [Related]
10. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni.
Akiba M; Lin J; Barton YW; Zhang Q
J Antimicrob Chemother; 2006 Jan; 57(1):52-60. PubMed ID: 16303882
[TBL] [Abstract][Full Text] [Related]
11. Formation of the Resistance of Campylobacter jejuni to Macrolide Antibiotics.
Efimochkina NR; Stetsenko VV; Sheveleva SA
Bull Exp Biol Med; 2020 Jul; 169(3):351-356. PubMed ID: 32748135
[TBL] [Abstract][Full Text] [Related]
12. A Highly Macrolide-Resistant Campylobacter jejuni Strain with Rare A2074T Mutations in 23S rRNA Genes.
Ohno H; Wachino J; Saito R; Jin W; Yamada K; Kimura K; Arakawa Y
Antimicrob Agents Chemother; 2016 Apr; 60(4):2580-1. PubMed ID: 26810658
[No Abstract] [Full Text] [Related]
13. Systematic identification of genetic loci required for polymyxin resistance in Campylobacter jejuni using an efficient in vivo transposon mutagenesis system.
Lin J; Wang Y; Hoang KV
Foodborne Pathog Dis; 2009 Mar; 6(2):173-185. PubMed ID: 19105633
[TBL] [Abstract][Full Text] [Related]
14. Campylobacter jejuni as a secondary colonizer of poultry biofilms.
Hanning I; Jarquin R; Slavik M
J Appl Microbiol; 2008 Oct; 105(4):1199-208. PubMed ID: 18557961
[TBL] [Abstract][Full Text] [Related]
15. A human health risk assessment for macrolide-resistant Campylobacter associated with the use of macrolides in Danish pig production.
Alban L; Nielsen EO; Dahl J
Prev Vet Med; 2008 Feb; 83(2):115-29. PubMed ID: 17659797
[TBL] [Abstract][Full Text] [Related]
16. A stochastic assessment of the public health risks of the use of macrolide antibiotics in food animals.
Hurd HS; Malladi S
Risk Anal; 2008 Jun; 28(3):695-710. PubMed ID: 18643826
[TBL] [Abstract][Full Text] [Related]
17. Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
Pasquali F; Lucchi A; Manfreda G
Int J Antimicrob Agents; 2008 May; 31(5):500-2. PubMed ID: 18329250
[No Abstract] [Full Text] [Related]
18. Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infection.
Lindow JC; Poly F; Tribble DR; Guerry P; Carmolli MP; Baqar S; Porter CK; Pierce KK; Darsley MJ; Sadigh KS; Dill EA; ; Kirkpatrick BD
J Clin Microbiol; 2010 Aug; 48(8):3012-5. PubMed ID: 20554818
[TBL] [Abstract][Full Text] [Related]
19. Persistence of Campylobacter jejuni on surfaces in a processing environment and on cutting boards.
Cools I; Uyttendaele M; Cerpentier J; D'Haese E; Nelis HJ; Debevere J
Lett Appl Microbiol; 2005; 40(6):418-23. PubMed ID: 15892736
[TBL] [Abstract][Full Text] [Related]
20. Survival and stress induced expression of groEL and rpoD of Campylobacter jejuni from different growth phases.
Klancnik A; Botteldoorn N; Herman L; Mozina SS
Int J Food Microbiol; 2006 Dec; 112(3):200-7. PubMed ID: 16782221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
